Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Nauka-Svyaz reported for 3 months of 2025 by RAS

4/30/25 NSVZ

Rusolovo reported for 3 months of 2025 by RAS

4/30/25 ROLO

UTair Aviation reported for 2024 by IFRS

4/30/25 UTAR

ZIL reported for 3 months of 2025 by RAS

4/30/25 ZILL

RESK reported for 3 months in by RAS

4/30/25 RZSB

Board of Directors of Ryazan Energy Supply Company recommended that dividends be paid for 2024

4/30/25 RZSB

Chelyabinsk Metallurgical Plant reported for 2024 under IFRS

4/30/25 CHMK

Saratovenergo reported for 3 months of 2025 by RAS

4/30/25 SARE

Red October reported for 2024 by IFRS

4/30/25 KROT

Shareholders of Ural Airlines approved dividends for 2024

4/30/25 URAL